General description
Recombinant human CEACAM8 extracellular domain.
~80-140 kDa observed. 35.52/38.15 kDa (mature/pro-form) calculated. The broad and smeary band appearance is consistent with the detection of differentially glycosylated CEACAM8 species.
Application
Epitope: Extracellular domain
Biochem/physiol Actions
Clone 6/40c specifically detected exogenously expressed human CEACAM8, but not CEACAM1/3/4/5/6/7, on the surface of transfected CHO cells.
Physical form
Purified mouse IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
Analysis Note
Evaluated by Western Blotting in PMN cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected CEACAM8 in 10 µg of PMN cell lysate.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
| conjugate | unconjugated |
| Quality Segment | 300 |
| antibody form | purified antibody |
| clone | 6/40c,monoclonal |
| purified by | using protein G |
| species reactivity | mouse, human |
| concentration | (Please refer to lot specific datasheet.) |
| technique(s) | ELISA: suitable,flow cytometry: suitable,immunohistochemistry: suitable,immunoprecipitation (IP): suitable,western blot: suitable |
| isotype | IgG1κ |
| UniProt accession no. | P31997 |
| target post-translational modification | unmodified |
